IncFact
Company Profiles: Revenue, Growth, Competition

Geneventiv Therapeutics Revenue, Growth & Competitor Profile

DBA GENEVENTIV THERAPEUTICS INC
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity

Company Profile & Annual Report for Geneventiv Therapeutics

Access the complete profile.

Geneventiv Therapeutics Fast Facts

RevenueN/A    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry N/A
Address312 Buncombe Street
Raleigh, NC 27609

Note: Revenues for privately held companies are statistical evaluations.


Geneventiv Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Geneventiv Therapeutics is classified as operating in the N/A industry, NAICS Code .


Investor Activity

Geneventiv Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
August 17, 2022 1 70%$2 MM
Complete list of funding rounds and total amounts in the Company Report




Nearby Competitors

These companies are similar in business line and location to Geneventiv Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
FIRST-CITIZENS BANK & TRUSTRaleigh, NC100 
BMC STOCK SERVICES BRaleigh, NC52 
QUALITY RESTAURANT GROUPRaleigh, NC49 
MARTIN MARIETTA MATERIALSRaleigh, NC46 
SWISSPORT NORTH AMERICA HOLDINGSRaleigh, NC43 
STATE EMPLOYEES CREDIT UNIONRaleigh, NC40 


(0.1791 s)



Future Competition: Geneventiv Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Geneventiv Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Geneventiv Therapeutics Competitors